2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

Sunday, December 13, 2026
06:00 p.m. - 08:00 p.m.
MCCNO - Hall F
Technology and Procedures, Assays, Omics Technologies, Pathology, Bioinformatics, Blood Banking, Computational Biology, Treatment Considerations, Non-Biological Therapies, Pharmacology, Artificial Intelligence (AI), Machine Learning, Biological Processes, Pathogenesis, Hematopoiesis, Immune Mechanism, Metabolism, Molecular Biology, Diseases, Bone Marrow Failure Syndromes, Acquired Marrow Failure Syndromes , Inherited Marrow Failure Syndromes, Myeloid Malignancies, Acute Myeloid Malignancies, Chronic Myeloid Malignancies, Research, Fundamental Science, AML, Translational Research, MDS, Study Population, Human, Elderly, Animal Model
PAPER

3821 Somatic cux1 mutagenesis exacerbates iron dyshomeostasis in ddx41 insufficiency driving aberrant erythropoiesis

Valerie Awad, Student, Teresa Bowman, PhD2
1 Albert Einstein College of Medicine, Bronx, New York, United States
2 Albert Einstein College of Medicine, Bronx, New York, United States

Heterozygous germline mutations in the DEAD-box helicase 41 (DDX41) gene predispose individuals to adult, late-onset myelodysplastic syndromes (MDS), a family of myeloid cancers involving defective hematopoietic stem and progenitor cells, maladaptive differentiation, and increased risk of leukemic transformation. Over 70% of MDS patients present with anemia driven by ineffective erythropoiesis, the severity of which independently predicts poor survival and correlates with high-risk somatic mutations. In patients with germline DDX41 mutations, somatic mutations in the second DDX41 allele are the most second hit mutation. In a zebrafish model of homozygous ddx41 loss-of-function, ddx41HOM embryos develop macrocytic anemia and diminished hemoglobinized erythroblasts suggesting iron homeostasis could be disrupted. We found that genes related to iron regulation are differentially expressed in ddx41HOM erythroblasts compared to control cells. Furthermore, the labile iron pool is significantly expanded in ddx41HOM erythroblasts at 36 hours post fertilization (hpf), which coincides with the onset of hemoglobinization. To determine which stage of erythroid maturation these changes were occurring, we dissected the erythroid compartment in ddx41HOM embryos using gata1:dsRed and globin-lcr:GFP. This approach uncovered a novel population expanded in ddx41HOM embryos of dysplastic erythroblasts with stressed morphological features including condensed darkened nuclei, fragmented chromatin, and coarse, granular cytoplasm with vacuole-like areas. Treatment with the iron chelator deferasirox (DFX) reduced both the number and frequency of these distressed erythroblasts.

 

In human patients with DDX41 germline mutations, somatic mutagenesis of the transcription factor CUT-like homeobox 1 (CUX1) is significantly enriched compared to MDS patients with wildtype DDX41. Moreover, mouse models of Cux1 insufficiency develop anemia with signs of stress erythropoiesis. Based on these findings, we generated a zebrafish system that mimics germline ddx41 mutations and somatic cux1 mutations to test for cooperativity in erythroid defects. Mutagenesis of cux1a, the zebrafish homolog of human CUX1, in ddx41HOM embryos further diminished basophilic and ortho-chromatophilic erythroblast numbers with a concomitant increase in distressed erythroblasts. Somatic mutagenesis of cux1a exacerbated iron deregulation as evidenced by a further elevation of the labile iron pool and lipid peroxidation in 36hpf ddx41HOM erythroblasts. Subsequently, by two days post-fertilization, ddx41HOM + cux1a co-mutated embryos accumulate higher levels of erythroblastic reactive oxygen species (ROS) and generate fewer functionally hemoglobinized cells than either mutation alone, indicating progressive oxidative stress following iron imbalance and concurrent with defects in erythroid maturation. Furthermore, cux1a mutagenesis is sufficient to unmask disrupted erythropoiesis in ddx41HET embryos which genetically mirror the human germline carrier state and show no discernible erythroid defect on their own. Somatic cux1a mutagenesis in ddx41HET embryos increased the number and frequency of stressed, dysplastic erythroblasts by 36hpf with a subsequent significant reduction in functionally hemoglobinized cells by 48hpf. Collectively, these findings establish that cux1a mutations coalesce with ddx41 insufficiency to disrupt iron homeostasis, fueling progressive ROS accumulation that culminates in dyserythropoiesis and hematopoietic failure, defining a novel mechanism for how DDX41/CUX1 co-mutations could promote MDS evolution.

Valerie Awad, Student: No relevant conflicts of interest to declare.